BioPharm International, September 2010 Issue (PDF)
Combine Mechanistic Modeling and DoE to Streamline QbD
REMS Program Challenges Manufacturers, Providers
Too many REMS cause headaches for doctors and the industry.
Label-Free and Labeled Technology for Protein Characterization and Quantitation
Use it label-free, or add labels to detect contaminants in solution.
Quality Management Systems for Small Biopharmaceutical Organizations
What small biotechs need to know about quality management systems.
Biosimilars Approvals in the US: The Path Forward
An in-depth analysis of the patent provisions of the new legislation.
Biosimilars, Part 3: Interchangeability
The third holy grail of biosimilars: interchangeability.
Build Versus Buy in the Current Biotech Market Environment
How current economic conditions affect your build-or-buy decision.
Design Space Development for Lyophilization Using DOE and Process Modeling
Develop a relevant design space without full factorial DoE.
